The 22nd edition of the Tour CIBC Charles-Bruneau a huge success
As more than $3 million raised for children with cancer
MONTREAL, July 7, 2017 — Amid a festive and euphoric atmosphere, the 600 cyclists in the 22nd Tour CIBC Charles-Bruneau were warmly welcomed today by their families, friends and colleagues as they arrived at their final destination after travelling more than 1,700 kilometres across Québec with the shared hope of putting an end to pediatric cancer.
The event’s nine spokespersons – Pierre and Ginette Bruneau, Paul Doucet, Pierre Jobin, Julie Marcoux, Luce Dufault, Alexandre Dubé, Hugo Giroux and Yvan Martineau – and all the cyclists who took part in the Tour celebrated the great success of this major cycling event, which surpassed its objective by raising a record $3,300,000. The proceeds will go towards the development of projects in the area of pediatric hematology and oncology.
In order to encourage the cyclists during the course of the event and attest to the importance of investing in pediatric oncology research, the cyclists received support from children with cancer or in remission. Taking part in this year’s event with their parents were Laurence Payette, 6, in remission after receiving treatment for acute lymphoblastic leukemia, Benjamin Perron, 8, in treatment for acute lymphoblastic leukemia, Steven Boudreau, 13, in treatment for leukemia, Zoé Antonecchia, 9, in remission after receiving treatment for stage-4 neuroblastoma, Charles Paradis, 16, in remission after receiving treatment for Hodgkin’s lymphoma, Joshua Rothman, 11, in treatment for a brain tumour, and close to 60 other children paired with cyclists.
The 2017 Tour CIBC Charles-Bruneau in numbers
- 22nd edition
- The 2017 edition took place on June 10 and from July 4 to 7
- 7 separate treks
- Close to 1,700 km
- Almost 600 cyclists
- Close to 100 volunteers
- More than 80 families
- More than $21 million raised since the first Tour in 1995
- $3 million raised in 2016
- 2017 objective: $3 million
- 2017 result: $3.3 million
- Next edition: July 3-6, 2018
Pediatric cancer in Québec
- Cancer is the leading cause of death due to illness among children aged 0 to 18;
- One child in 400 is diagnosed with cancer before the age of 15;
- More than half of children with cancer are diagnosed before the age of 5.
About the Fondation Charles-Bruneau
The Fondation Charles-Bruneau recently made a commitment to invest $22M in research. Two objectives serve to guide researchers: curing the 20% of children whose cancer is resistant to treatment, and improving the quality of life of children in remission so that they can enjoy a true recovery, free of side-effects and complications. This five-year commitment is certainly ambitious, but the Fondation is confident that it will be able to count on support from its loyal partners and the public.
Over the past 27 years, a sum of $15 million has been invested in research and $40 million has been invested in the construction, development and procurement of a hospital centre and three Charles-Bruneau pediatric oncology units in Québec.